18 BlackRock Lilly(Eli) Trades
BlackRock's position in Lilly(Eli) is currently worth $71.9B. That's 1.10% of their equity portfolio (12th largest holding). The investor owns 6.91% of the outstanding Lilly(Eli) stock. The first Lilly(Eli) trade was made in Q4 2020. Since then BlackRock bought shares ten more times and sold shares on seven occasions. The stake costed the investor $13.8B, netting the investor a gain of 420% so far.
News about Lilly(Eli) & Co and BlackRock
Eli Lilly Stock Hits Record Highs, Becomes First Pharmaceutical Firm Worth $1 Trillion
Eli Lilly (LLY) stock has surged to new record highs of over $1,000 a share, cementing its position as one of the market's most dominant growth stories and t...
President Trump Loaded Up on Eli Lilly in Q1. Should You Buy the Obesity Drug Stock Too?
Eli Lilly's fundamentals matter more than Trump's stock purchases.
Eli Lilly to Expand Vaccine Pipeline With Three Biotech Buyouts
LLY plans $3.83B in biotech buyouts to expand into vaccines and infectious diseases beyond obesity and diabetes.
Lilly to participate in Goldman Sachs 47th Annual Global Healthcare Conference
INDIANAPOLIS, May 27, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on...